Free Trial

Basel Medical Group (BMGL) Competitors

$4.40 +0.09 (+2.09%)
As of 03:05 PM Eastern

BMGL vs. CELC, PSNL, VMD, DCGO, LFMD, CORBF, TOI, SERA, AIRS, and EUDA

Should you be buying Basel Medical Group stock or one of its competitors? The main competitors of Basel Medical Group include Celcuity (CELC), Personalis (PSNL), Viemed Healthcare (VMD), DocGo (DCGO), LifeMD (LFMD), Global Cord Blood (CORBF), Oncology Institute (TOI), Sera Prognostics (SERA), AirSculpt Technologies (AIRS), and EUDA Health (EUDA). These companies are all part of the "healthcare" industry.

Basel Medical Group vs.

Basel Medical Group (NASDAQ:BMGL) and Celcuity (NASDAQ:CELC) are both small-cap services companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment, valuation and community ranking.

Basel Medical Group has higher revenue and earnings than Celcuity.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Basel Medical Group$10.05M7.91N/AN/AN/A
CelcuityN/AN/A-$63.78M-$2.81-3.60

Celcuity has a consensus target price of $30.17, suggesting a potential upside of 198.38%. Given Celcuity's stronger consensus rating and higher probable upside, analysts plainly believe Celcuity is more favorable than Basel Medical Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Basel Medical Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Celcuity
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14

Basel Medical Group's return on equity of 0.00% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
Basel Medical GroupN/A N/A N/A
Celcuity N/A -62.66%-39.78%

63.3% of Celcuity shares are owned by institutional investors. 15.8% of Celcuity shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Celcuity had 2 more articles in the media than Basel Medical Group. MarketBeat recorded 4 mentions for Celcuity and 2 mentions for Basel Medical Group. Celcuity's average media sentiment score of 0.31 beat Basel Medical Group's score of -0.50 indicating that Celcuity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Basel Medical Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative
Celcuity
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Celcuity received 341 more outperform votes than Basel Medical Group when rated by MarketBeat users.

CompanyUnderperformOutperform
Basel Medical GroupN/AN/A
CelcuityOutperform Votes
341
67.79%
Underperform Votes
162
32.21%

Summary

Celcuity beats Basel Medical Group on 9 of the 12 factors compared between the two stocks.

Remove Ads
Get Basel Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMGL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BMGL vs. The Competition

MetricBasel Medical GroupServices – Health IndustryServices SectorNASDAQ Exchange
Market Cap$79.54M$44.72M$2.56B$7.57B
Dividend YieldN/AN/AN/A4.32%
P/E RatioN/AN/A2.5517.82
Price / Sales7.917.9122.6194.61
Price / CashN/AN/AN/A34.64
Price / BookN/AN/AN/A4.00
Net IncomeN/A-$40,000.00N/A$247.23M
7 Day PerformanceN/AN/A6.43%1.45%
1 Month PerformanceN/AN/A-1.78%-6.24%
1 Year PerformanceN/AN/A-22.33%0.60%

Basel Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BMGL
Basel Medical Group
N/A$4.40
+2.1%
N/AN/A$81.20M$10.05M0.0036
CELC
Celcuity
1.7078 of 5 stars
$8.65
flat
$30.17
+248.7%
-44.1%$327.31MN/A-3.3140
PSNL
Personalis
3.7974 of 5 stars
$3.03
-10.4%
$7.80
+157.4%
+158.7%$267.44M$84.61M-1.80400Gap Down
VMD
Viemed Healthcare
0.9762 of 5 stars
$6.53
-1.8%
N/A-18.8%$258.08M$224.26M24.19630Short Interest ↑
Positive News
DCGO
DocGo
2.9436 of 5 stars
$2.50
-2.7%
$4.89
+95.7%
-30.8%$254.96M$616.56M8.932,920Positive News
LFMD
LifeMD
2.6767 of 5 stars
$4.98
-4.2%
$11.43
+129.5%
-46.3%$222.03M$212.45M-7.78230Gap Down
CORBF
Global Cord Blood
N/A$1.15
flat
N/A-48.0%$139.78M$196.12M0.001,200Gap Down
TOI
Oncology Institute
0.3926 of 5 stars
$1.69
+7.6%
N/A+59.7%$127.70M$393.41M-2.17660Gap Down
SERA
Sera Prognostics
0.5237 of 5 stars
$3.11
-10.1%
N/A-67.1%$117.14M$77,000.00-3.14120Gap Down
AIRS
AirSculpt Technologies
1.287 of 5 stars
$1.80
-12.6%
$3.75
+108.3%
-68.0%$105.44M$180.35M-12.86240Gap Down
EUDA
EUDA Health
0.3847 of 5 stars
$3.65
+4.0%
N/A+121.3%$89.89M$3.81M0.002Short Interest ↑
Gap Up
Remove Ads

Related Companies and Tools


This page (NASDAQ:BMGL) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners